Neoplastic (malignant) related fatigue
ICD-10 R53.0 is a billable code used to indicate a diagnosis of neoplastic (malignant) related fatigue.
Neoplastic (malignant) related fatigue is a debilitating condition often experienced by patients with cancer. This fatigue is distinct from general fatigue as it is primarily associated with the presence of malignant tumors and can significantly impact a patient's quality of life. Symptoms may include persistent tiredness, lack of energy, and a decreased ability to perform daily activities. Patients may also report cognitive impairments, such as difficulty concentrating or memory issues. The fatigue can be exacerbated by factors such as chemotherapy, radiation therapy, pain, anemia, and psychological stress. Clinically, it is essential to differentiate this fatigue from other causes, as it may require specific management strategies tailored to the underlying malignancy and its treatment. Laboratory findings may reveal anemia, electrolyte imbalances, or other abnormalities that contribute to the fatigue. Accurate identification and coding of this condition are crucial for appropriate treatment and resource allocation.
Detailed patient history, including cancer diagnosis, treatment regimen, and symptom assessment.
Patients presenting with fatigue during or after cancer treatment.
Consideration of comorbid conditions that may contribute to fatigue.
Acute assessment of fatigue in the context of cancer treatment, including vital signs and lab results.
Patients with acute fatigue exacerbation due to treatment side effects.
Rapid evaluation of potential complications related to malignancy.
Used for follow-up visits where fatigue is assessed in the context of cancer treatment.
Document the patient's cancer history, treatment effects, and fatigue assessment.
Internal medicine and oncology practices should ensure comprehensive documentation.
Documentation should include the patient's cancer diagnosis, treatment history, and a clear description of how the fatigue is related to the malignancy.
